Tapewire

Nasdaq · USD

HIT

Health In Tech, Inc.

Export transactions ↓
Tapewire entity
7078
SEC CIK
0002019505
Parsed reports
69

Last 12 months

Inside the activity.

0 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202604
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 07, 2026 Filed Oct 9, 2026 20:30 UTC GrantClass A Common Stock 26,301 $0.76 $19,988.76
Disclosure

SEC source: 0001213900-26-108500 · ownership.xml · nonDerivative · entry 1

Howard William D. · CIK 0001993318 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164,811

F1 · shares: Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vested as of their grant date.

Read SEC document
October 07, 2026 Filed Oct 9, 2026 20:30 UTC GrantClass A Common Stock 26,301 $0.76 $19,988.76
Disclosure

SEC source: 0001213900-26-108502 · ownership.xml · nonDerivative · entry 1

Hayes Timothy · CIK 0002020283 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,081

F1 · shares: Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vested as of their grant date.

Read SEC document
September 15, 2026 Filed Sep 16, 2026 21:21 UTC
Hasan Zain SyedChief Growth Officer
Tax withholdingClass A Common Stock 4,795 $0.89 $4,267.55
Disclosure

SEC source: 0001213900-26-100594 · ownership.xml · nonDerivative · entry 1

Hasan Zain Syed · CIK 0002102674 · Chief Growth Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 183,749

F1 · shares: Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

F2 · balance_after: Includes 168,538 restricted shares of Class A Common Stock and 15,211 unrestricted shares of Class A Common Stock.

Read SEC document
September 15, 2026 Filed Sep 16, 2026 21:21 UTC
Qian LinLinDirector · Chief Executive Officer · 10% owner
Tax withholdingClass A Common Stock 33,725 $0.89 $30,015.25
Disclosure

SEC source: 0001213900-26-100592 · ownership.xml · nonDerivative · entry 1

Qian LinLin · CIK 0001849454 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,964,667

F1 · shares: Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

F2 · balance_after: Includes 887,062 restricted shares of Class A Common Stock and 8,077,605 unrestricted shares of Class A Common Stock. Excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.

Read SEC document
September 15, 2026 Filed Sep 16, 2026 21:20 UTC
Johnson Tim DonaldDirector · Chief Executive Officer · 10% owner
Tax withholdingClass A Common Stock 63,339 $0.89 $56,371.71
Disclosure

SEC source: 0001213900-26-100590 · ownership.xml · nonDerivative · entry 1

Johnson Tim Donald · CIK 0001993657 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,271,026

F1 · shares: Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

F2 · balance_after: Includes 755,592 restricted shares of Class A Common Stock and 22,515,434 unrestricted shares of Class A Common Stock. Excludes 9,000,000 shares of Class B Common Stock and 734,707 options to purchase shares of Class A Common Stock.

Read SEC document
September 14, 2026 Filed Sep 15, 2026 20:05 UTC SaleClass A Common Stock 12,000 $0.89 $10,716.00
Disclosure

SEC source: 0001213900-26-100128 · ownership.xml · nonDerivative · entry 1

Hayes Timothy · CIK 0002020283 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,780

F1 · shares: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.8694 to $0.943 per share, inclusive. The reporting person undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
September 11, 2026 Filed Sep 14, 2026 12:55 UTC
Hasan Zain SyedChief Growth Officer
SaleClass A Common Stock 11,667 $0.92 $10,733.64
Disclosure

SEC source: 0001213900-26-099471 · ownership.xml · nonDerivative · entry 1

Hasan Zain Syed · CIK 0002102674 · Chief Growth Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 188,544

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2026.

F2 · balance_after: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.9103 to $0.9541 per share, inclusive. The reporting person undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
September 11, 2026 Filed Sep 12, 2026 01:14 UTC SaleClass A Common Stock 12,000 $0.91 $10,920.00
Disclosure

SEC source: 0001213900-26-099421 · ownership.xml · nonDerivative · entry 2

Hayes Timothy · CIK 0002020283 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,780

Read SEC document
September 09, 2026 Filed Sep 12, 2026 01:14 UTC SaleClass A Common Stock 5,730 $0.93 $5,328.90
Disclosure

SEC source: 0001213900-26-099421 · ownership.xml · nonDerivative · entry 1

Hayes Timothy · CIK 0002020283 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 132,780

Read SEC document
August 13, 2026 Filed Aug 17, 2026 20:31 UTC
Qian LinLinDirector · Chief Financial Officer · 10% owner
Tax withholdingClass A Common Stock 28,183 $1.06 $29,873.98
Disclosure

SEC source: 0001213900-26-090796 · ownership.xml · nonDerivative · entry 1

Qian LinLin · CIK 0001849454 · Director · Chief Financial Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,998,392

F1 · shares: Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

F2 · balance_after: Includes 938,743 restricted shares of Class A Common Stock and 8,059,649 unrestricted shares of Class A Common Stock. Excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.

Read SEC document
August 13, 2026 Filed Aug 17, 2026 20:30 UTC
Johnson Tim DonaldDirector · Chief Executive Officer · 10% owner
Tax withholdingClass A Common Stock 46,327 $1.06 $49,106.62
Disclosure

SEC source: 0001213900-26-090793 · ownership.xml · nonDerivative · entry 1

Johnson Tim Donald · CIK 0001993657 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,334,365

F1 · shares: Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

F2 · balance_after: Includes 842,491 restricted shares of Class A Common Stock and 22,491,874 unrestricted shares of Class A Common Stock. Excludes 9,000,000 shares of Class B Common Stock and 734,707 options to purchase shares of Class A Common Stock.

Read SEC document
August 13, 2026 Filed Aug 17, 2026 20:30 UTC
Hasan Zain SyedChief Growth Officer
Tax withholdingClass A Common Stock 4,007 $1.06 $4,247.42
Disclosure

SEC source: 0001213900-26-090790 · ownership.xml · nonDerivative · entry 1

Hasan Zain Syed · CIK 0002102674 · Chief Growth Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,211

F1 · shares: Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

F2 · balance_after: Includes 179,326 restricted shares of Class A Common Stock and 20,885 unrestricted shares of Class A Common Stock.

Read SEC document
July 15, 2026 Filed Jul 17, 2026 22:52 UTC
Hasan Zain SyedChief Growth Officer
Tax withholdingClass A Common Stock 4,084 $1.04 $4,247.36
Disclosure

SEC source: 0001213900-26-079326 · ownership.xml · nonDerivative · entry 1

Hasan Zain Syed · CIK 0002102674 · Chief Growth Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 204,218

F1 · shares: Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

F2 · balance_after: Includes 189,249 restricted shares of Class A Common Stock and 14,969 unrestricted shares of Class A Common Stock.

Read SEC document
July 15, 2026 Filed Jul 17, 2026 22:52 UTC
Qian LinLinDirector · Chief Financial Officer · 10% owner
Tax withholdingClass A Common Stock 28,725 $1.04 $29,874.00
Disclosure

SEC source: 0001213900-26-079323 · ownership.xml · nonDerivative · entry 1

Qian LinLin · CIK 0001849454 · Director · Chief Financial Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,026,575

F1 · shares: Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

F2 · balance_after: Includes 984,340 restricted shares of Class A Common Stock and 8,042,235 unrestricted shares of Class A Common Stock. Excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.

Read SEC document
July 15, 2026 Filed Jul 17, 2026 22:52 UTC
Johnson Tim DonaldDirector · Chief Executive Officer · 10% owner
Tax withholdingClass A Common Stock 47,217 $1.04 $49,105.68
Disclosure

SEC source: 0001213900-26-079324 · ownership.xml · nonDerivative · entry 1

Johnson Tim Donald · CIK 0001993657 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,380,692

F1 · shares: Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

F2 · balance_after: Includes 911,932 restricted shares of Class A Common Stock and 22,468,760 unrestricted shares of Class A Common Stock. Excludes 9,000,000 shares of Class B Common Stock and 734,707 options to purchase shares of Class A Common Stock.

Read SEC document
July 08, 2026 Filed Jul 10, 2026 18:45 UTC GrantClass A Common Stock 18,867 $1.06 $19,999.02
Disclosure

SEC source: 0001213900-26-077301 · ownership.xml · nonDerivative · entry 1

Hayes Timothy · CIK 0002020283 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,510

F1 · shares: Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vested as of their grant date.

Read SEC document
July 08, 2026 Filed Jul 10, 2026 22:46 UTC GrantClass A Common Stock 18,867 $1.06 $19,999.02
Disclosure

SEC source: 0001213900-26-077303 · ownership.xml · nonDerivative · entry 1

Shrestha Sanjay K · CIK 0001775802 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,200

F1 · shares: Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vested as of their grant date.

Read SEC document
July 08, 2026 Filed Jul 10, 2026 22:46 UTC GrantClass A Common Stock 18,867 $1.06 $19,999.02
Disclosure

SEC source: 0001213900-26-077302 · ownership.xml · nonDerivative · entry 1

Howard William D. · CIK 0001993318 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,510

F1 · shares: Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vested as of their grant date.

Read SEC document
June 15, 2026 Filed Jun 18, 2026 12:55 UTC
Hasan Zain SyedChief Growth Officer
Tax withholdingClass A Common Stock 4,045 $1.05 $4,247.25
Disclosure

SEC source: 0001213900-26-069895 · ownership.xml · nonDerivative · entry 1

Hasan Zain Syed · CIK 0002102674 · Chief Growth Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 208,302

F1 · shares: Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

F2 · balance_after: Includes 199,288 restricted shares of Class A Common Stock and 9,014 unrestricted shares of Class A Common Stock.

Read SEC document
June 15, 2026 Filed Jun 18, 2026 12:54 UTC
Johnson Tim DonaldDirector · Chief Executive Officer · 10% owner
Tax withholdingClass A Common Stock 46,768 $1.05 $49,106.40
Disclosure

SEC source: 0001213900-26-069893 · ownership.xml · nonDerivative · entry 1

Johnson Tim Donald · CIK 0001993657 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,427,909

F1 · shares: Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

F2 · balance_after: Includes 984,353 restricted shares of Class A Common Stock and 22,443,556 unrestricted shares of Class A Common Stock. Excludes 9,000,000 shares of Class B Common Stock and 734,707 options to purchase shares of Class A Common Stock.

Read SEC document
June 15, 2026 Filed Jun 18, 2026 12:52 UTC
Qian LinLinDirector · Chief Financial Officer · 10% owner
Tax withholdingClass A Common Stock 28,451 $1.05 $29,873.55
Disclosure

SEC source: 0001213900-26-069891 · ownership.xml · nonDerivative · entry 1

Qian LinLin · CIK 0001849454 · Director · Chief Financial Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,055,300

F1 · shares: Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

F2 · balance_after: Includes 1,030,065 restricted shares of Class A Common Stock and 8,025,235 unrestricted shares of Class A Common Stock. Excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.

Read SEC document
May 20, 2026 Filed May 22, 2026 20:38 UTC
Lockett Jonathan DelChief Strategy Officer
GrantClass A Common Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-060621 · ownership.xml · nonDerivative · entry 1

Lockett Jonathan Del · CIK 0001994792 · Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 143,539

F1 · shares: Represents restricted shares of Class A Common Stock granted pursuant to the Health In Tech Equity Incentive Plan which shall be automatically forfeited without consideration unless certain performance-based milestones are achieved. 20,000 shares shall vest in equal monthly installments over 12 months, commencing on or before July 1, 2026, if the first milestone is achieved by such date. The remaining 30,000 shares shall vest in equal monthly installments over 12 months, commencing on or before August 15, 2026, if the second milestone is achieved by such date.

F2 · balance_after: Includes 78,985 unrestricted shares of Class A Common Stock and 64,554 restricted shares of Class A Common Stock. Excludes 165,085 options to purchase shares of Class A Common Stock.

Read SEC document
May 14, 2026 Filed May 18, 2026 21:26 UTC
Qian LinLinDirector · Chief Financial Officer · 10% owner
Tax withholdingClass A Common Stock 23,324 $1.23 $28,688.52
Disclosure

SEC source: 0001213900-26-058571 · ownership.xml · nonDerivative · entry 1

Qian LinLin · CIK 0001849454 · Director · Chief Financial Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,083,751

F1 · shares: Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

F2 · balance_after: Includes 1,060,738 restricted shares of Class A Common Stock and 8,023,013 unrestricted shares of Class A Common Stock. Excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.

Read SEC document
May 14, 2026 Filed May 18, 2026 21:24 UTC
Johnson Tim DonaldDirector · Chief Executive Officer · 10% owner
Tax withholdingClass A Common Stock 39,924 $1.23 $49,106.52
Disclosure

SEC source: 0001213900-26-058567 · ownership.xml · nonDerivative · entry 1

Johnson Tim Donald · CIK 0001993657 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,474,677

F1 · shares: Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

F2 · balance_after: Includes 1,037,478 restricted shares of Class A Common Stock and 22,437,199 unrestricted shares of Class A Common Stock. Excludes 9,000,000 shares of Class B Common Stock and 734,707 options to purchase shares of Class A Common Stock.

Read SEC document
May 14, 2026 Filed May 18, 2026 21:23 UTC
Hasan Zain SyedChief Growth Officer
Tax withholdingClass A Common Stock 4,205 $1.23 $5,172.15
Disclosure

SEC source: 0001213900-26-058564 · ownership.xml · nonDerivative · entry 1

Hasan Zain Syed · CIK 0002102674 · Chief Growth Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 212,347

F1 · shares: Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

F2 · balance_after: Includes 205,680 restricted shares of Class A Common Stock and 6,667 unrestricted shares of Class A Common Stock.

Read SEC document
April 15, 2026 Filed Apr 17, 2026 20:50 UTC
Hasan Zain SyedChief Growth Officer
Tax withholdingClass A Common Stock 3,448 $1.50 $5,172.00
Disclosure

SEC source: 0001213900-26-045214 · ownership.xml · nonDerivative · entry 1

Hasan Zain Syed · CIK 0002102674 · Chief Growth Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 216,552

F1 · shares: Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4 filed on January 8, 2026.

F2 · balance_after: Includes 211,552 restricted shares of Class A Common Stock and 5,000 unrestricted shares of Class A Common Stock.

Read SEC document
April 15, 2026 Filed Apr 17, 2026 20:50 UTC
Qian LinLinDirector · Chief Financial Officer · 10% owner
Tax withholdingClass A Common Stock 21,480 $1.50 $32,220.00
Disclosure

SEC source: 0001213900-26-045212 · ownership.xml · nonDerivative · entry 1

Qian LinLin · CIK 0001849454 · Director · Chief Financial Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,107,075

F1 · shares: Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4 filed on January 8, 2026.

F2 · balance_after: Includes 1,086,284 restricted shares of Class A Common Stock and 8,020,791 unrestricted shares of Class A Common Stock. Excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.

Read SEC document
April 15, 2026 Filed Apr 17, 2026 20:49 UTC
Johnson Tim DonaldDirector · Chief Executive Officer · 10% owner
Tax withholdingClass A Common Stock 35,140 $1.50 $52,710.00
Disclosure

SEC source: 0001213900-26-045210 · ownership.xml · nonDerivative · entry 1

Johnson Tim Donald · CIK 0001993657 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,514,601

F1 · shares: Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4 filed on January 8, 2026.

F2 · balance_after: Includes 1,079,624 restricted shares of Class A Common Stock and 222,434,977 unrestricted shares of Class A Common Stock. Excludes 9,000,000 shares of Class B Common Stock and 734,707 options to purchase shares of Class A Common Stock.

Read SEC document
April 15, 2026 Filed Apr 20, 2026 21:40 UTC Amendment
Johnson Tim DonaldDirector · Chief Executive Officer · 10% owner
Tax withholdingClass A Common Stock 35,140 $1.50 $52,710.00
Disclosure

SEC source: 0001213900-26-045741 · ownership.xml · nonDerivative · entry 1

Johnson Tim Donald · CIK 0001993657 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,514,601

F1 · shares: Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4 filed on January 8, 2026.

F2 · balance_after: Includes 1,079,624 restricted shares of Class A Common Stock and 22,434,977 unrestricted shares of Class A Common Stock. Excludes 9,000,000 shares of Class B Common Stock and 734,707 options to purchase shares of Class A Common Stock.

Read SEC document
April 10, 2026 Filed Apr 13, 2026 23:25 UTC
McStravock JohnGeneral Counsel
GrantClass A Common Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-043124 · ownership.xml · nonDerivative · entry 1

McStravock John · CIK 0002128743 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

F1 · shares: Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The restricted shares vest in equal monthly instalments over a twelve (12) month period, commencing on April 6, 2026, subject to the reporting person's continued service with the registrant through each applicable vesting date.

Read SEC document
April 08, 2026 Filed Apr 11, 2026 00:42 UTC GrantClass A Common Stock 13,598 $1.36 $18,493.28
Disclosure

SEC source: 0001213900-26-042696 · ownership.xml · nonDerivative · entry 1

Hayes Timothy · CIK 0002020283 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 119,643

F1 · shares: Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vested as of their grant date.

Read SEC document
April 08, 2026 Filed Apr 11, 2026 00:42 UTC GrantClass A Common Stock 13,598 $1.36 $18,493.28
Disclosure

SEC source: 0001213900-26-042697 · ownership.xml · nonDerivative · entry 1

Howard William D. · CIK 0001993318 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 119,643

F1 · shares: Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vested as of their grant date.

Read SEC document
April 08, 2026 Filed Apr 11, 2026 00:42 UTC GrantClass A Common Stock 13,598 $1.36 $18,493.28
Disclosure

SEC source: 0001213900-26-042698 · ownership.xml · nonDerivative · entry 1

Shrestha Sanjay K · CIK 0001775802 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,333

F1 · shares: Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vested as of their grant date.

Read SEC document
January 06, 2026 Filed Jan 9, 2026 02:27 UTC
Hasan Zain SyedChief Growth Officer
GrantClass A Common Stock 200,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-002660 · ownership.xml · nonDerivative · entry 1

Hasan Zain Syed · CIK 0002102674 · Chief Growth Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 220,000

F1 · shares: Represents restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan in connection with two proposed issuer transactions (each, a "Transaction"). Half of the shares vest in equal monthly installments over 12 months starting at the closing of the first Transaction ("First Transaction Shares"). The other half vest in equal monthly installments over 12 months starting at the closing of the second Transaction ("Second Transaction Shares"). Vesting is subject to continued service. If either Transaction does not close within 24 months after January 6, 2026 (the "Grant Date"), unvested shares relating to that Transaction will be automatically forfeited without consideration.

F2 · balance_after: Includes 220,000 shares of restricted shares of Class A Common Stock.

Read SEC document
January 06, 2026 Filed Jan 9, 2026 02:27 UTC
Johnson Tim DonaldDirector · Chief Executive Officer · 10% owner
GrantClass A Common Stock 1,000,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-002659 · ownership.xml · nonDerivative · entry 1

Johnson Tim Donald · CIK 0001993657 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,549,741

F1 · shares: Represents restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan in connection with two proposed issuer transactions (each, a "Transaction"). Half of the shares vest in equal monthly installments over 12 months starting at the closing of the first Transaction ("First Transaction Shares"). The other half vest in equal monthly installments over 12 months starting at the closing of the second Transaction ("Second Transaction Shares"). Vesting is subject to continued service. If either Transaction does not close within 24 months after January 6, 2026 (the "Grant Date"), unvested shares relating to that Transaction will be automatically forfeited without consideration.

F2 · balance_after: Includes 1,126,130 shares of restricted shares of Class A Common Stock and 22,423,611 unrestricted shares of Class A Common Stock. Excludes 9,000,000 shares of Class B Common Stock and 734,707 options to purchase shares of Class A Common Stock.

Read SEC document
January 06, 2026 Filed Jan 9, 2026 02:27 UTC
Qian LinLinDirector · Chief Financial Officer · 10% owner
GrantClass A Common Stock 1,000,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-002658 · ownership.xml · nonDerivative · entry 1

Qian LinLin · CIK 0001849454 · Director · Chief Financial Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,128,555

F1 · shares: Represents restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan in connection with two proposed issuer transactions (each, a "Transaction"). Half of the shares vest in equal monthly installments over 12 months starting at the closing of the first Transaction ("First Transaction Shares"). The other half vest in equal monthly installments over 12 months starting at the closing of the second Transaction ("Second Transaction Shares"). Vesting is subject to continued service. If either Transaction does not close within 24 months after January 6, 2026 (the "Grant Date"), unvested shares relating to that Transaction will be automatically forfeited without consideration.

F2 · balance_after: Includes 1,119,130 shares of restricted shares of Class A Common Stock and 8,009,425 unrestricted shares of Class A Common Stock. Excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.

Read SEC document
November 05, 2025 Filed Nov 7, 2025 19:01 UTC GrantClass A Common Stock 8,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-107767 · ownership.xml · nonDerivative · entry 1

Clarkson Michael David · CIK 0002095354 · CISO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,000

F1 · shares: Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The restricted shares vest in equal monthly instalments over a twelve (12) month period commencing on November 1, 2025, subject to the reporting person's continued service with the issuer through each applicable vesting date.

Read SEC document
October 08, 2025 Filed Oct 10, 2025 21:21 UTC GrantClass A Common Stock 5,730 $3.49 $19,997.70
Disclosure

SEC source: 0001213900-25-098193 · ownership.xml · nonDerivative · entry 2

Hayes Timothy · CIK 0002020283 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,045

F2 · shares: Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vest quarterly commencing upon the date of grant, subject to the reporting person's continuous service through the vesting date.

F3 · balance_after: Includes 5,730 shares of restricted stock and 100,315 shares of Class A Common Stock.

Read SEC document
October 08, 2025 Filed Oct 10, 2025 21:20 UTC GrantClass A Common Stock 5,730 $3.49 $19,997.70
Disclosure

SEC source: 0001213900-25-098192 · ownership.xml · nonDerivative · entry 2

Shrestha Sanjay K · CIK 0001775802 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,735

F2 · shares: Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vest quarterly commencing upon the date of grant, subject to the reporting person's continuous service through the vesting date.

F3 · balance_after: Includes 5,730 shares of restricted stock and 63,005 shares of Class A Common Stock.

Read SEC document
October 08, 2025 Filed Oct 10, 2025 21:22 UTC GrantClass A Common Stock 5,730 $3.49 $19,997.70
Disclosure

SEC source: 0001213900-25-098194 · ownership.xml · nonDerivative · entry 2

Howard William D. · CIK 0001993318 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,045

F2 · shares: Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vest quarterly commencing upon the date of grant, subject to the reporting person's continuous service through the vesting date.

F3 · balance_after: Includes 5,730 shares of restricted stock and 100,315 shares of Class A Common Stock.

Read SEC document
October 03, 2025 Filed Oct 10, 2025 21:21 UTC Disposition to issuerClass A Common Stock 28,159 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-098193 · ownership.xml · nonDerivative · entry 1

Hayes Timothy · CIK 0002020283 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,315

F1 · shares: Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan, which were subject to forfeiture on a pro-rata basis upon the issuer's annual stockholders meeting held on October 3, 2025.

Read SEC document
October 03, 2025 Filed Oct 10, 2025 21:20 UTC Disposition to issuerClass A Common Stock 65,469 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-098192 · ownership.xml · nonDerivative · entry 1

Shrestha Sanjay K · CIK 0001775802 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,005

F1 · shares: Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan, which were subject to forfeiture on a pro-rata basis upon the issuer's annual stockholders meeting held on October 3, 2025.

Read SEC document
October 03, 2025 Filed Oct 10, 2025 21:22 UTC Disposition to issuerClass A Common Stock 28,159 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-098194 · ownership.xml · nonDerivative · entry 1

Howard William D. · CIK 0001993318 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,315

F1 · shares: Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan, which were subject to forfeiture on a pro-rata basis upon the issuer's annual stockholders meeting held on October 3, 2025.

Read SEC document
September 24, 2025 Filed Sep 26, 2025 23:20 UTC
Plantholt DustinChief AI & Marketing Officer
GrantClass A Common Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-092541 · ownership.xml · nonDerivative · entry 1

Plantholt Dustin · CIK 0002062449 · Chief AI & Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,000

F1 · shares: Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. One third (1/3) of the shares of restricted stock granted to the reporting person shall vest in equal monthly installments over a twelve (12) month period commencing on the date a letter of intent or memorandum of understanding is signed in connection with an initiative being developed by the Company (the "Initiative"), one third (1/3) of the shares shall vest in equal monthly installments over a twelve (12) month period commencing on the date the Initiative enters proof-of-concept or beta launch, and, the remaining one third (1/3) of the shares shall vest in equal monthly installments over a twelve (12) month period commencing on the date of full commercial launch of the Initiative.

F2 · balance_after: Includes 50,000 shares of restricted stock and 14,000 unrestricted shares of Class A Common Stock.

Read SEC document
September 24, 2025 Filed Sep 26, 2025 23:19 UTC
Qian LinLinDirector · Chief Financial Officer · 10% owner
GrantClass A Common Stock 80,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-092540 · ownership.xml · nonDerivative · entry 1

Qian LinLin · CIK 0001849454 · Director · Chief Financial Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,128,555

F1 · shares: Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. One third (1/3) of the shares of restricted stock granted to the reporting person shall vest in equal monthly installments over a twelve (12) month period commencing on the date a letter of intent or memorandum of understanding is signed in connection with an initiative being developed by the Company (the "Initiative"), one third (1/3) of the shares shall vest in equal monthly installments over a twelve (12) month period commencing on the date the Initiative enters proof-of-concept or beta launch, and, the remaining one third (1/3) of the shares shall vest in equal monthly installments over a twelve (12) month period commencing on the date of full commercial launch of the Initiative.

F2 · balance_after: Includes 130,495 shares of restricted stock and 7,998,060 shares of Class A Common Stock. Excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.

Read SEC document
September 24, 2025 Filed Sep 30, 2025 01:00 UTC
Johnson Tim DonaldDirector · Chief Executive Officer · 10% owner
GrantClass A Common Stock 80,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-093326 · ownership.xml · nonDerivative · entry 1

Johnson Tim Donald · CIK 0001993657 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,549,741

F1 · shares: Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. One third (1/3) of the shares of restricted stock granted to the reporting person shall vest in equal monthly installments over a twelve (12) month period commencing on the date a letter of intent or memorandum of understanding is signed in connection with an initiative being developed by the Company (the "Initiative"), one third (1/3) of the shares shall vest in equal monthly installments over a twelve (12) month period commencing on the date the Initiative enters proof-of-concept or beta launch, and, the remaining one third (1/3) of the shares shall vest in equal monthly installments over a twelve (12) month period commencing on the date of full commercial launch of the Initiative.

F2 · balance_after: Includes 137,495 shares of restricted stock and 22,412,246 shares of Class A Common Stock. Excludes 9,000,000 shares of Class B Common Stock and 734,707 options to purchase shares of Class A Common Stock.

Read SEC document
August 15, 2025 Filed Aug 19, 2025 19:00 UTC
Yousuf Imran MohammedChief Technology Officer
GrantClass A Common Stock 7,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-078629 · ownership.xml · nonDerivative · entry 1

Yousuf Imran Mohammed · CIK 0002041942 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,000

F1 · shares: Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. Fifty percent (50%) of the shares of restricted stock granted to the reporting person shall vest in equal monthly installments over a twelve (12) month period commencing on the date that the first of two specified programs being developed by the Company is successfully launched and fully operational in the marketplace, and the remaining fifty percent (50%) shall vest in equal monthly installments over a twelve (12) month period commencing on the date that the other specified program being developed by the Company is successfully launched and fully operational in the marketplace.

F2 · balance_after: Includes 100,000 shares of Class A Common Stock and 7,000 shares of restricted stock. Excludes 100,000 options to purchase shares of Class A Common Stock.

Read SEC document
August 15, 2025 Filed Aug 19, 2025 23:00 UTC
Qian LinLinDirector · Chief Financial Officer · 10% owner
GrantClass A Common Stock 27,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-078631 · ownership.xml · nonDerivative · entry 1

Qian LinLin · CIK 0001849454 · Director · Chief Financial Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,048,555

F1 · shares: Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. Fifty percent (50%) of the shares of restricted stock granted to the reporting person shall vest in equal monthly installments over a twelve (12) month period commencing on the date that the first of two specified programs being developed by the Company is successfully launched and fully operational in the marketplace, and the remaining fifty percent (50%) shall vest in equal monthly installments over a twelve (12) month period commencing on the date that the other specified program being developed by the Company is successfully launched and fully operational in the marketplace.

F2 · balance_after: Includes 55,193 shares of restricted stock and 7,993,362 shares of Class A Common Stock. Excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.

Read SEC document
August 15, 2025 Filed Aug 19, 2025 23:00 UTC
Lockett Jonathan DelChief Strategy Officer
GrantClass A Common Stock 7,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-078628 · ownership.xml · nonDerivative · entry 1

Lockett Jonathan Del · CIK 0001994792 · Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,539

F1 · shares: Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. Fifty percent (50%) of the shares of restricted stock granted to the reporting person shall vest in equal monthly installments over a twelve (12) month period commencing on the date that the first of two specified programs being developed by the Company is successfully launched and fully operational in the marketplace, and the remaining fifty percent (50%) shall vest in equal monthly installments over a twelve (12) month period commencing on the date that the other specified program being developed by the Company is successfully launched and fully operational in the marketplace.

F2 · balance_after: Includes 71,434 shares of Class A Common Stock and 22,105 shares of restricted stock. Excludes 165,085 options to purchase shares of Class A Common Stock.

Read SEC document
August 15, 2025 Filed Aug 19, 2025 23:00 UTC
Johnson Tim DonaldDirector · Chief Executive Officer · 10% owner
GrantClass A Common Stock 34,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-078630 · ownership.xml · nonDerivative · entry 1

Johnson Tim Donald · CIK 0001993657 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,469,741

F1 · shares: Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. Fifty percent (50%) of the shares of restricted stock granted to the reporting person shall vest in equal monthly installments over a twelve (12) month period commencing on the date that the first of two specified programs being developed by the Company is successfully launched and fully operational in the marketplace, and the remaining fifty percent (50%) shall vest in equal monthly installments over a twelve (12) month period commencing on the date that the other specified program being developed by the Company is successfully launched and fully operational in the marketplace.

F2 · balance_after: Includes 62,193 shares of restricted stock and 22,407,548 shares of Class A Common Stock. Excludes 9,000,000 shares of Class B Common Stock and 734,707 options to purchase shares of Class A Common Stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.